Apical hypertrophic cardiomyopathy: Present status

Affiliations

Aurora Cardiovascular Services, Aurora Sinai/Aurora St. Luke's Medical Centers

Abstract

Since the first description of apical hypertrophic cardiomyopathy in Japan 40years ago, contrasting information from all over the world has emerged regarding the natural history of the disease. This review provides an overview of incidence, phenotypic expressions, clinical features, prognosis, and management of this heterogeneous clinical entity, which may play a more relevant role in the burden of sudden cardiac death than previously thought.

Document Type

Article

PubMed ID

27521551

Link to Full Text

 

Share

COinS